search
Back to results

Portable Monitoring for Diagnosis and Management of Sleep Apnea (HomePAP)

Primary Purpose

Sleep Apnea, Obstructive

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex)
Standard polysomnography (PSG)
Sponsored by
Case Western Reserve University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Apnea, Obstructive focused on measuring treatment, positive airway pressure, compliance, cost effectiveness, clinical trial

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Intermediate to high probability of having OSA based on an adjusted neck circumference > 43 cm (17 inches)
  • Presence of excessive daytime sleepiness (Epworth sleepiness scale ≥ 12) Apnea-hypopnea index >= 15 on diagnostic testing to continue in study

Exclusion Criteria:

  • Severe chronic insomnia, other condition with < 4 hrs of sleep per night
  • Unstable medical conditions
  • Major psychiatric diagnosis
  • Unable to undergo home testing
  • Concerns about unsafe driving
  • Severe COPD or restrictive lung disease
  • Chronic narcotic use
  • Alcohol abuse
  • History of cataplexy
  • Moderate to severe restless legs syndrome symptoms
  • Pre-existing diagnosis of sleep apnea
  • Prior experience with positive airway pressure treatment of sleep apnea
  • Anticipated upper airway surgery or gastric bypass surgery in 4 months
  • Decisional impairment for consenting
  • Hypoventilation syndrome, identified in the medical record
  • Waking oxygen saturation < 92%

Sites / Locations

  • University Hospitals Case Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

laboratory-based testing

home-based testing

Outcomes

Primary Outcome Measures

Acceptance of CPAP treatment

Secondary Outcome Measures

Compliance with CPAP therapy

Full Information

First Posted
March 24, 2008
Last Updated
May 25, 2010
Sponsor
Case Western Reserve University
Collaborators
University Hospitals Cleveland Medical Center, The Cleveland Clinic, MetroHealth Medical Center, University of Washington, University of Minnesota, Northwestern University, University of Wisconsin, Madison
search

1. Study Identification

Unique Protocol Identification Number
NCT00642486
Brief Title
Portable Monitoring for Diagnosis and Management of Sleep Apnea
Acronym
HomePAP
Official Title
Portable Monitoring in the Diagnosis and Management of Obstructive Sleep Apnea
Study Type
Interventional

2. Study Status

Record Verification Date
March 2008
Overall Recruitment Status
Completed
Study Start Date
February 2008 (undefined)
Primary Completion Date
July 2009 (Actual)
Study Completion Date
March 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Case Western Reserve University
Collaborators
University Hospitals Cleveland Medical Center, The Cleveland Clinic, MetroHealth Medical Center, University of Washington, University of Minnesota, Northwestern University, University of Wisconsin, Madison

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This multi-site project compares compares the efficiency of a home-based portable monitoring strategy to a standard of care sleep laboratory-based strategy for the diagnosis and positive airway pressure treatment of obstructive sleep apnea in adults.
Detailed Description
The study is a randomized, parallel group, unblinded, multicenter study that compares two approaches [home-based, portable monitoring (PM) versus attended, laboratory-based polysomnography (PSG) (Lab)] in adults, at least 18 years of age, with a moderate to high probability of obstructive sleep apnea (OSA) and who have been referred to sleep medicine specialists at AASM-accredited sleep centers for evaluation and/or management. The study is designed to compare the utility of the two approaches (PM group vs. Lab group) for the diagnosis and management of OSA in adults. Approximately 372 eligible adults will be randomized at screening to either the PM or Lab arm (186 per arm), undergo baseline OSA testing to confirm diagnosis and study eligibility, then receive positive airway pressure (PAP) titration studies to determine the level of pressure needed to treat their OSA. For qualifying participants, the titration study will be lab-based in the Lab group and be home-based using a commercially available portable, automatic PAP device (APAP) in the PM group. All qualifying study participants will have access to study CPAP equipment and supplies to treat their OSA. Primary outcomes (time from diagnosis to effective treatment, patient outcomes, and relative resource utilization) are determined at 1 and 3 months after starting CPAP treatment. Study participants who complete all of their study visits will keep their CPAP machine at the end of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive
Keywords
treatment, positive airway pressure, compliance, cost effectiveness, clinical trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
373 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
laboratory-based testing
Arm Title
2
Arm Type
Active Comparator
Arm Description
home-based testing
Intervention Type
Other
Intervention Name(s)
Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex)
Intervention Description
portable, home-based using the Embla Embletta X30 system as the diagnostic device and the Respironic REMStar Auto M series with CFlex as the PAP titration device.
Intervention Type
Other
Intervention Name(s)
Standard polysomnography (PSG)
Intervention Description
laboratory-based testing
Primary Outcome Measure Information:
Title
Acceptance of CPAP treatment
Time Frame
from diagnosis to effective treatment
Secondary Outcome Measure Information:
Title
Compliance with CPAP therapy
Time Frame
1 and 3 month post acceptance

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Intermediate to high probability of having OSA based on an adjusted neck circumference > 43 cm (17 inches) Presence of excessive daytime sleepiness (Epworth sleepiness scale ≥ 12) Apnea-hypopnea index >= 15 on diagnostic testing to continue in study Exclusion Criteria: Severe chronic insomnia, other condition with < 4 hrs of sleep per night Unstable medical conditions Major psychiatric diagnosis Unable to undergo home testing Concerns about unsafe driving Severe COPD or restrictive lung disease Chronic narcotic use Alcohol abuse History of cataplexy Moderate to severe restless legs syndrome symptoms Pre-existing diagnosis of sleep apnea Prior experience with positive airway pressure treatment of sleep apnea Anticipated upper airway surgery or gastric bypass surgery in 4 months Decisional impairment for consenting Hypoventilation syndrome, identified in the medical record Waking oxygen saturation < 92%
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carol L Rosen, MD
Organizational Affiliation
Case Western Reserve University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals Case Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34870587
Citation
Pascoe M, Bena J, Andrews ND, Auckley D, Benca R, Billings ME, Kapur VK, Iber C, Zee PC, Redline S, Rosen CL, Foldvary-Schaefer N. Dose-response relationship between positive airway pressure therapy and excessive daytime sleepiness: the HomePAP study. J Clin Sleep Med. 2022 Apr 1;18(4):1027-1034. doi: 10.5664/jcsm.9792.
Results Reference
derived
PubMed Identifier
26118558
Citation
Kim RD, Kapur VK, Redline-Bruch J, Rueschman M, Auckley DH, Benca RM, Foldvary-Schafer NR, Iber C, Zee PC, Rosen CL, Redline S, Ramsey SD. An Economic Evaluation of Home Versus Laboratory-Based Diagnosis of Obstructive Sleep Apnea. Sleep. 2015 Jul 1;38(7):1027-37. doi: 10.5665/sleep.4804.
Results Reference
derived
PubMed Identifier
25325491
Citation
Billings ME, Rosen CL, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Zee PC, Redline S, Kapur VK. Psychometric performance and responsiveness of the functional outcomes of sleep questionnaire and sleep apnea quality of life instrument in a randomized trial: the HomePAP study. Sleep. 2014 Dec 1;37(12):2017-24. doi: 10.5665/sleep.4262.
Results Reference
derived
PubMed Identifier
23372269
Citation
Billings ME, Rosen CL, Wang R, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Zee P, Redline S, Kapur VK. Is the relationship between race and continuous positive airway pressure adherence mediated by sleep duration? Sleep. 2013 Feb 1;36(2):221-7. doi: 10.5665/sleep.2376.
Results Reference
derived
PubMed Identifier
22654195
Citation
Rosen CL, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Kapur V, Rueschman M, Zee P, Redline S. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. Sleep. 2012 Jun 1;35(6):757-67. doi: 10.5665/sleep.1870.
Results Reference
derived
PubMed Identifier
22131602
Citation
Billings ME, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Redline S, Rosen CL, Zee P, Kapur VK. Race and residential socioeconomics as predictors of CPAP adherence. Sleep. 2011 Dec 1;34(12):1653-8. doi: 10.5665/sleep.1428.
Results Reference
derived

Learn more about this trial

Portable Monitoring for Diagnosis and Management of Sleep Apnea

We'll reach out to this number within 24 hrs